Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells

被引:32
作者
Schlager, S
Speck, SH
Woisetschlager, M
机构
[1] WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110
[3] SANDOZ GMBH,FORSCHUNGSINST,A-1235 VIENNA,AUSTRIA
[4] KARL FRANZENS UNIV GRAZ,INST MICROBIOL,A-8010 GRAZ,AUSTRIA
关键词
D O I
10.1128/JVI.70.6.3561-3570.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to gain insights into the regulation of Epstein-Barr virus (EBV) gene transcription during the establishment of viral latency in B cells. During the early stages of EBV infection in B lymphocytes, transcription of six viral nuclear antigens (EBNAs) is initiated from an early promoter (Wp). This is followed by a switch of promoter usage to an upstream promoter, Cp, whose activity is autoregulated by both EBNA1 and EBNA2. Previously it was demonstrated that infection of primary B cells with EBNA2-negative (EBNA2(-)) EBNA4-mutant (EBNA4(mut)) virus resulted only in the expression of mutant EBNA4 protein and failure to express the other EBNA gene products (C. Rooney, H. G. Howe, S. H. Speck, and G. Miller, J. Virol. 63:1531-1539, 1989). We extended this research to demonstrate that Wp-to-Cp switching did not occur upon infection of primary B cells with an EBNA2(-) EBNA4(mut) virus (M. Woisetschlaeger, X. W. Jin, C. N. Yandara, L. A. Furmanski, J. L. Strominger, and S. H. Speck, Proc. Natl. Acad. Sci. USA 88:3942-3946, 1991). Further characterization of this phenomenon led to the identification of an EBNA2-dependent enhancer upstream of Cp. On the basis of these data, a model was proposed in which initial transcription from Wp gives rise to the expression of EBNA2 and EBNA4, and then transcription is upregulated from Cp via the EBNA2-dependent enhancer (Woisetschlaeger et al., as noted above). Implicit in this model is that transcription of the EBNA1 and EBNA3a to -3c genes is dependent on the switch from Wp to Cp, since primary cells infected with EBNA2(-) EBNA4(mut) virus fail to switch and also fail to express these viral antigens. Here we critically evaluate this model and demonstrate, in contrast to the predictions of the model, that transcription of both the EBNA1 and EBNA2 genes precedes activation of Cp. Furthermore, the level of EBNA1 gene transcription was strongly reduced in primary B cells infected with EBNA2(-) EBNA4(mut) virus compared with that of cells infected with wild-type virus. Switching to Cp, as well as EBNA1 gene transcription, was observed upon infection of EBV-negative Burkitt's lymphoma (BL) cell lines with EBNA2(-) EBNA4(mut) virus, thus establishing a correlation between early EBNA1 gene transcription and upregulation of transcription initiation from Cp. However, in EBV-negative BL cell lines infected with EBNA2(-) EBNA4(mut) virus, transcription of the EBNA1 gene at early time points postinfection initiated from Qp, the EBNA1 gene promoter active in group I BL cells (B. C. Schaefer, J. L. Strominger, and S. H. Speck, Proc. Natl. Acad. Sci. USA 92:10565-10569, 1995), rather than from Wp. The data support a model in which EBNA1 plays an important role in the cascade of events leading to successful switching from Wp to Cp and subsequent immortalization of the infected B cell.
引用
收藏
页码:3561 / 3570
页数:10
相关论文
共 42 条
[1]  
AMAN P, 1985, J IMMUNOL, V135, P2362
[2]  
AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303
[3]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[4]   NUCLEIC-ACID SPOT HYBRIDIZATION - RAPID QUANTITATIVE SCREENING OF LYMPHOID-CELL LINES FOR EPSTEIN-BARR VIRAL-DNA [J].
BRANDSMA, J ;
MILLER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (11) :6851-6855
[5]   EPSTEIN-BARR-VIRUS (EBV) INDUCES EXPRESSION OF B-CELL ACTIVATION MARKERS ON INVITRO INFECTION OF EBV-NEGATIVE B-LYMPHOMA CELLS [J].
CALENDER, A ;
BILLAUD, M ;
AUBRY, JP ;
BANCHEREAU, J ;
VUILLAUME, M ;
LENOIR, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8060-8064
[6]  
CHUJOR CSN, 1992, CLIN EXP IMMUNOL, V87, P398
[7]  
FARRELL PJ, 1989, ADV VIRAL ONCOL, V8, P103
[8]  
GHAN TA, 1995, J VIROL, V69, P2633
[9]  
GORDON J, 1986, IMMUNOLOGY, V58, P591
[10]   MASKING OF THE CBF1/RBPJ(KAPPA) TRANSCRIPTIONAL REPRESSION DOMAIN BY EPSTEIN-BARR-VIRUS EBNA2 [J].
HSIEH, JJD ;
HAYWARD, SD .
SCIENCE, 1995, 268 (5210) :560-563